TavTech

Company Overview

Snapshot

Founded in March 1996, TavTech operates with 11–50 employees. The company specializes in advanced medical and aesthetic applications, notably distributing its JetPeel PRP handpiece for pain-free treatments.

Business overview

TavTech develops advanced medical and aesthetic applications utilizing its proprietary jet technology. The company's core products include JetPeel technology for non-invasive aesthetic treatments, designed to deliver effective results without pain or downtime, and the Jetox wound management system for efficient cleansing and debridement. TavTech primarily serves the medical aesthetics and healthcare provider markets, operating within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Aesthetic Devices.

Company Intelligence Q&A

What is TavTech's primary focus?

TavTech is committed to developing advanced medical and aesthetic applications based on its proprietary jet technology, aiming for more effective treatments across various conditions.

What is the JetPeel technology?

JetPeel technology is TavTech's solution for revolutionary aesthetic treatments, offering a non-invasive delivery system designed to achieve superior results without pain, needles, scar tissue, or downtime.

What is the purpose of the Jetox wound management system?

The Jetox wound management system provides physicians and nurses with an advanced yet simple cleansing and debridement application to accelerate healing with minimal equipment and maximum compatibility in any medical setting.

Which markets does TavTech serve?

TavTech focuses on the world of medical aesthetics and provides solutions for healthcare providers, operating within the broader Health Tech & Life Sciences sector.

What was a key distribution partnership for TavTech?

In November 2018, NY Laser Outlet began distributing TavTech Ltd.’s new state-of-the-art JetPeel PRP handpiece in the U.S. market, enabling pain-free platelet-rich plasma (PRP) treatments.